MFDS — authorised 22 March 1950
- Marketing authorisation holder: BAXTER HLTHCARE
- Status: likely_approved
🇰🇷 Wydase in South Korea
MFDS authorised Wydase on 22 March 1950
Marketing authorisation
Wydase in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Wydase approved in South Korea?
Yes. MFDS authorised it on 22 March 1950.
Who is the marketing authorisation holder for Wydase in South Korea?
BAXTER HLTHCARE holds the South Korean marketing authorisation.